IRIS
DEFERRARI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.884
Totale 17.884
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 17.884
Totale 17.884
Salva come PNG Salva come JPEG
Città #
Genova 14.508
Rapallo 2.153
Genoa 1.172
Bordighera 51
Totale 17.884
Salva come PNG Salva come JPEG
Nome #
L'AMMONIOGENESI RENALE NELL'UOMO 242
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 147
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 146
Interorgan exchange of aminothiols in humans 137
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. 133
Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase 132
Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells 132
Inter-organ leptin exchange in humans 128
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 126
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 126
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 126
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 124
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 124
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 123
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy 122
Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. 121
Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis 120
Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis. 120
Creatinine clearance and early signs of target organ damage in primary hypertension 120
C-reactive protein and target organ damage in untreated patients with primary hypertension. 120
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. 119
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 116
Mild renal dysfunction and renal vascular resistance in primary hypertension 116
Mechanisms of renal ammonia production and protein turnover 116
PROTEIN TURNOVER IN THE HUMAN KIDNEY 115
Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study 115
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 115
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 115
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 114
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 114
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 114
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 113
Phenylalanine hydroxylation across the kidney in humans 112
Renal ammoniagenesis in an early stage of metabolic acidosis in man 112
Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II 112
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 112
AMINO ACID METABOLISM AND THE LIVER IN RENAL FAILURE 111
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 111
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 111
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 109
Renal and cardiac abnormalities in primary hypertension 109
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 109
Renal metabolism of C peptide in type I (insulin-dependent) diabetic patients 108
LEG METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL FAILURE 108
Blood pressure variability and multiple organ damage in primary hypertension 107
RENAL METABOLISM OF C-PEPTIDE IN MAN 105
Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells 105
Splanchnic exchange of amino acids after amino acid ingestion in patients with chronic renal insufficiency 105
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 105
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 104
Treatment of diabetic nephropathy in its early stages 104
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 103
Disposal of exogenous amino acids by muscle in patients with chronic renal failure 103
Vascular permeability, blood pressure, and organ damage in primary hypertension 102
EFFECTS OF CHRONIC RENAL INSUFFICIENCY AND METABOLIC ACIDOSIS ON GLUTAMINE METABOLISM IN MAN 101
Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. 101
Serum uric acid as a marker of target organ damage in primary hypertension 101
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 100
Amino acid imbalance in patients with chronic renal failure. 100
SPLANCHNIC AMINO ACID AND PROTEIN TURNOVER IN HUMANS: INSIGHT FROM ISOTOPE DILUTION AND CATHETERIZATION STUDIES 99
Amino acid metabolism, substrate availability and the control of protein dynamics in the human kidney 99
LEUCINE METABOLISM AND PROTEIN DYNAMICS IN THE HUMAN KIDNEY 99
Renal ammoniagenesis in humans with chronic potassium depletion 99
Skeletal muscle protein synthesis and degradation in patients with chronic renal failure 97
Target organ damage and metabolic syndrome in non diabetic hypertensive patients 97
Global risk stratification in primary hypertension: the role of the kidney 97
TT virus infection in haemodialysis patients 97
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 97
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 97
RENAL AMMONIAGENESIS IN THE POST-PRANDIAL PERIOD 96
Sub-clinical organ damage in hypertension and obesity 96
Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure 95
Muscle protein synthesis and degradation in hemodialysis (HD) patients with protein-energy malnutrition (PEM) 95
Renal ammoniagenesis during the adaptation to metabolic acidosis in man. 95
Abnormal amino acid metabolism after amino acid ingestion in chronic renal failure 95
Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised? 94
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 93
Apoptosis induced by serum withdrawal in human mesangial cells. Role of IGFBP-3 93
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 93
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 92
BRAIN METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY 92
SUCCESSFUL TREATMENT OF MITOMYCIN C-ASSOCIATED HEMOLYTIC UREMIC SYNDROME BY PLASMAPHERESIS 92
Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care. 92
DETERMINANTS OF THE PARTITION OF RENAL AMMONIA PRODUCTION BETWEEN URINE AND VENOUS BLOOD IN MAN WITH METABOLIC ACID-BASE DISTURBANCES 92
Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment. 92
Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC Study 91
Metabolic syndrome and microalbuminuria predict renal outcome in non-diabetic patients with primary hypertension: the MAGIC study. 91
Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications. 90
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 90
Left ventricular geometry and function in patients with essential hypertension and microalbuminuria 90
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 90
Importance of blood pressure control in chronic kidney disease 90
EFFECTS OF HEMODIALYSIS ON GUANIDINO-PROPIONIC ACID METABOLISM 90
WHOLE BODY AND ORGAN PROTEIN TURNOVER IN CHRONIC RENAL FAILURE 89
Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes. 89
Role of blood cells in leucine kinetics across the human kidney 89
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 88
Metabolic alkalosis in diabetic ketosis: a case report 88
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. I. Studies in the postabsorptive state 88
Microalbuminuria blood pressure load, and systemic vascular permeability in primary hypertension 88
Totale 10.737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.285
article - articoli 38.513
book - libri 0
conference - conferenze 2.173
curatela - curatele 0
other - altro 366
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.233
Totale 86.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019919 0 0 0 0 0 0 0 0 0 185 411 323
2019/20205.034 187 114 246 261 458 595 776 290 412 937 575 183
2020/20211.284 72 124 110 87 69 122 110 119 142 111 110 108
2021/20222.592 56 213 142 322 126 187 192 589 69 215 152 329
2022/20232.571 240 115 30 265 421 489 3 238 462 14 248 46
2023/2024804 66 165 19 108 80 151 43 88 75 9 0 0
Totale 18.016